Company Description
Some athletes take drugs for better performance, but what can a drug take to improve its performance? A new route! XenoPort is working to improve...
Key XenoPort Financials
| Company Type | Public - NASDAQ (GM): XNPT Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $113.8 |
| 2007 Employees | 181 |
More XenoPort Financials (11 pages)
Latest XenoPort Jobs jobs by Indeed
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about XenoPort's competition across multiple industries
Top XenoPort Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
XenoPort Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| CEO and Director | Ronald W. (Ron) Barrett | Network | E-mail |
| President | William J. (Bill) Rieflin | Network | E-mail |
| SVP Finance and CFO | William G. (Bill) Harris | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current XenoPort News
- SUSTAINED RELEASE ORAL DOSAGE FORMS OF A PRODRUG OF R-BACLOFEN AND METHODS OF TREATMENT [PCT Biblio Info] (22 Jul 2008 14:08:00 EDT)
- XenoPort, Inc. (XNPT) Corporate Event Announcement Notice [Wall Street Horizon] (19 Jul 2008 21:18:00 EDT)
- CATECHOL PROTECTED LEVODOPA DIESTER PRODRUGS, COMPOSITIONS, AND METHODS OF USE [PCT Biblio Info] (08 Jul 2008 16:59:00 EDT)







